Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Rajat, Mohindra"'
Autor:
Jarushka Naidoo, Guru Sonpavde, Mark A Socinski, Rajat Mohindra, Corey Carter, Laurent Essioux, Gonzalo Durán-Pacheco, G Scott Chandler, Vidya Maiya, Javier Puente, Jose Vicente Cardona
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 11 (2024)
Background The association between safety and efficacy of immune checkpoint inhibitors is known, but the correlation between severity and impact of specific organ involvement by immune-related adverse events (irAE) and cancer outcomes is poorly under
Externí odkaz:
https://doaj.org/article/100889036cf64217add58eb422d43d5d
Autor:
Zia Khan, Min Jung, Megan Crow, Rajat Mohindra, Vidya Maiya, Joshua S. Kaminker, David H. Hackos, G. Scott Chandler, Mark I. McCarthy, Tushar Bhangale
Publikováno v:
Genome Medicine, Vol 15, Iss 1, Pp 1-15 (2023)
Abstract Background Dose-limiting toxicities significantly impact the benefit/risk profile of many drugs. Whole genome sequencing (WGS) in patients receiving drugs with dose-limiting toxicities can identify therapeutic hypotheses to prevent these tox
Externí odkaz:
https://doaj.org/article/8203af64f2254efdb0211f8800973199
Autor:
David Roe, Ira Mellman, Mark McCarthy, Ashis Saha, Rajat Mohindra, Christian Hammer, Cameron Adams, G Scott Chandler
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/a9ad185c44b745b893e6606efca62005
Autor:
Thomas Powles, Sanjeev Mariathasan, Rajat Mohindra, G Scott Chandler, Corey Carter, Katrin Madjar, Bogdana I Balas, Laurent Essioux, Viraj Degaonkar
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/bb878d74a8b546d89c2326fb092c5031
Autor:
Evan J Lipson, Jarushka Naidoo, Julie Brahmer, Ludmila Danilova, Elizabeth M Jaffee, Won Jin Ho, Mark Yarchoan, Maximilian F Konig, Yasser Ged, Jean Hoffman-Censits, Jennifer Durham, Laura Cappelli, Sanjay Bansal, Aanika Balaji, Rajat Mohindra, Stephanie L Alden, Tanguy Y Seiwert, Chester J Kao, Soren Charmsaz, Madalena Brancati, Howard L Li, Kabeer Munjal, Hua-Ling Tsai, Alexei Hernandez, Nicole Gross, Erin M Coyne, Sarah M Shin, Brian Christmas, Christopher Thoburn, Marina Barretti, Rachel Garonce-Hediger, Laura Tang, G Scott Chandler
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/9ecf458f7da7428ea7c6e82123a0c044
Autor:
Katrin Madjar, Rajat Mohindra, Gonzalo Durán-Pacheco, Rashad Rasul, Laurent Essioux, Vidya Maiya, G. Scott Chandler
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundImmune checkpoint inhibitors (ICIs) have revolutionized the treatment of cancer patients in the last decade, but immune-related adverse events (irAEs) pose significant clinical challenges. Despite advances in the management of these unique
Externí odkaz:
https://doaj.org/article/3908e581aa5f492fbf36449ebc775e8e
Autor:
Christine Spencer, Shahneen Sandhu, Ira Mellman, Zia Khan, Julie Hunkapiller, Samantha Bucktrout, Ashis Saha, Jonathan Carroll, Claudia Yanez Arellano, Nicholas Bayless, Leonardo Nissola, Roslyn Wallace, Rajat Mohindra, G. Scott Chandler, Christian Hammer
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/629d7e62efc34dd9a228dc2109fa9d0c
Autor:
David Roe, Howard Rosoff, Dan Fu Ruan, Zia Khan, Pranay Dogra, Jonathan Carroll, Julie Hunkapiller, Rajat Mohindra, Minu K. Srivastava, Barzin Y. Nabet, G. Scott Chandler, Matthew L. Albert, Mark I. McCarthy, Ira Mellman, Amir Horowitz, Christian Hammer
Natural killer (NK) cells are educated through the binding of killer immunoglobulin like receptors (KIR) to human leukocyte antigen (HLA) proteins, but it is unknown whether the presence of these highly diverse KIR/HLA interactions influence response
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b773af8f060a1dc565a7958fea1a593b
https://doi.org/10.1101/2022.12.06.22282592
https://doi.org/10.1101/2022.12.06.22282592
Autor:
Hannah Barman, Sriram Venkateswaran, Antonio Del Santo, Krishna Rao, Bharathwaj Raghunatha, Unice Yoo, Lisa Kottschade, Matthew Block, G Scott Chandler, Tyler Wagner, Rajat Mohindra
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Zia Khan, Min Jung, Megan Crow, Rajat Mohindra, Vidya Maiya, Joshua Kaminker, David Hackos, G. Scott Chandler, Mark McCarthy, Tushar Bhangale
Dose-limiting toxicities significantly impact the benefit/risk profile of many drugs. Whole genome sequencing (WGS) in patients receiving drugs with dose-limiting toxicities can identify therapeutic hypotheses to prevent these toxicities. Peripheral
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::475494e22eba51cbe498b2e4669edc38
https://doi.org/10.21203/rs.3.rs-1816977/v1
https://doi.org/10.21203/rs.3.rs-1816977/v1